David Loew
Chief Executive Officer at
IPSEN
Net worth: 16 M $ as of 2026-05-30
Profile
David G. Loew is Chief Executive Officer & Director at Ipsen SA and Chief Executive Officer at Ipsen Pharma SAS (a subsidiary of Ipsen SA). In the past he was Executive Vice President-Sanofi Pasteur at Sanofi and Global Head-Product Strategy at Genentech, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IPSEN SA 0.1% | 2025-12-30 | 86,940 ( 0.1% ) | 16 M $ | 2026-05-30 |
Latest news about David Loew
David Loew active positions
| Companies | Position | Start |
|---|---|---|
| IPSEN | Chief Executive Officer | 2020-06-30 |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chairman | 2020-07-29 |
G5 Santé | Director/Board Member | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Director/Board Member | - |
Ipsen Biopharmaceuticals, Inc.
 Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Chief Executive Officer | 2020-06-30 |
Former positions of David Loew
| Companies | Position | End |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 2020-06-14 |
GAVI Alliance
 GAVI Alliance Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Director/Board Member | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Training of David Loew
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GAVI Alliance
GAVI Alliance Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
University of St. Gallen
 University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
G5 Santé |
- Stock Market
- Insiders
- David Loew
